Found 8 matching trials
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
PHASE3This protocol will evaluate the efficacy and safety of various combinations...
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
PHASE3The overall objective of this trial is to identify a safe and effective com...
Location
Kala-azar medical centre
Combination Therapy in Indian Visceral Leishmaniasis
PHASE3Rationale
The overall objective of this trial is to identify a safe and ef...
Location
Kala-azar Medical Research Center
Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)
PHASE3MAMS4CL comprises a clinical trial with three embedded sub-studies designed...
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
PHASE2Cure rate for L braziliensis bolivian CL has been 70%-80% for standard syst...
Location
Hopital, Dermatologico
Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)
PHASE2The cell behavior that the investigators regard as "malignant," including: ...
Location
Dr. Frank Arguello Cancer Clinic
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
PHASE3This is an open label, Phase III, randomized, controlled, parallel arm mult...
Location
Abdurafi MSF Health Center
Short Course Regimens for Treatment of PKDL (Sudan)
PHASE2This is an open label, randomized non comparative phase II clinical trial c...
Location
Prof. Elhassan Centre for tropical Medicine